Medical Doctor Program year 2022 Reported 2019–2022 Source: CMS Open Payments, 2026 publication

Karen Kinney

Emergency Medicine Wilmington, NC Medical Doctor

NPI 1760474175 CMS profile 868445

3408 Wilshire Blvd, 100, Wilmington, NC 28403

Open in the dashboard

General payments

$2,717

199 records reported · program years 2019–2022

Research payments

$0

Paid to them · None reported · program years 2019–2022

Ownership & investment interest

$0

None reported

Through program year 2022, Karen Kinney of Wilmington, NC is reported in the CMS Open Payments database as having received $2,717 across 199 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Emergency Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2022 General $152 9
2021 General $1,186 82
2020 General $754 60
2019 General $625 48

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Karen Kinney
  • Emergency Medicine median
  • Middle half of Emergency Medicine
  • National median

In program year 2025, general payments to Karen Kinney were reported at $0. Among 10,690 Emergency Medicine profiles paid that year, the median was $57 and the middle half received between $24 and $150.

Show as a table
Year Karen Kinney Emergency Medicine median Middle half National median
2019 $625 $51 $18–$128 $163
2020 $754 $29 $16–$99 $114
2021 $1,186 $40 $18–$124 $132
2022 $152 $49 $20–$134 $149
2023 $0 $51 $22–$142 $160
2024 $0 $52 $22–$150 $164
2025 $0 $57 $24–$150 $169

Breakdown

Who paid General payments · program years 2019–2022
  1. Otsuka America Pharmaceutical, Inc. $452 26 payments
  2. Sunovion Pharmaceuticals Inc. $405 35 payments
  3. Allergan Inc. $305 34 payments
  4. Alkermes, Inc. $301 18 payments
  5. AbbVie, Inc. $248 17 payments
  6. Janssen Pharmaceuticals, Inc $228 18 payments
  7. Lundbeck LLC $167 11 payments
  8. Indivior Inc. $153 10 payments
  9. ITI, Inc. $125 7 payments
  10. Vanda Pharmaceuticals Inc. $120 7 payments
  11. Other $213 16 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2022
  1. Food and Beverage $2,713 198 payments
  2. Education $5 1 payment
Products named General payments · program years 2019–2022
  1. LATUDA $405 35 payments
  2. VRAYLAR Neuroscience $305 34 payments
  3. ARISTADA INITIO $301 18 payments
  4. ARISTADA Cns $301 18 payments
  5. ARISTADA Cns $301 18 payments
  6. VRAYLAR Neuroscience $248 17 payments
  7. ARISTADA Cns $242 15 payments
  8. ARISTADA Cns $242 15 payments
  9. REXULTI $231 13 payments
  10. ABILIFY MAINTENA $220 13 payments
  11. Other $1,347 90 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

199 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record